Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medipharm Labs Corp MEDIF


Primary Symbol: T.LABS

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Recent & Breaking News (TSX:LABS)

MediPharm Labs Sets Date to Report Third Quarter 2022 Financial Results

PR Newswire November 9, 2022

MediPharm Labs (TSX:LABS) sells Australian facility

John Ballem  October 7, 2022

MediPharm Labs Completes Sale of Australian Facility for Proceeds of $7,250,000 AUD

PR Newswire October 7, 2022

MediPharm Labs Reports Second Quarter Results

PR Newswire August 15, 2022

MediPharm Labs Sets Date to Report Second Quarter 2022 Financial Results

PR Newswire August 11, 2022

MediPharm (TSX:LABS) signs research agreement with USC

Trevor Abes  August 9, 2022

MediPharm Labs Enters Cannabis Research Agreement with Keck School of Medicine of USC

PR Newswire August 9, 2022

MediPharm Labs (TSX:LABS) awarded favourable judgement

John Ballem  July 27, 2022

MediPharm Labs Awarded Payment of $9.8M in Connection to a 2020 Statement of Claim Against a Previous Customer

PR Newswire July 27, 2022

MediPharm Labs (TSX:LABS) sells Australian subsidiary

Trevor Abes  July 11, 2022

MediPharm Labs Enters into $6.2M Purchase Agreement for the Sale of Australian Facility

Canada NewsWire July 11, 2022

MediPharm Labs Announces Voting Results From the 2022 Annual Meeting of Shareholders

PR Newswire June 30, 2022

MediPharm Labs Reports First Quarter Results

PR Newswire May 16, 2022

MediPharm Labs Sets Date to Report First Quarter 2022 Financial Results

PR Newswire May 12, 2022

MediPharm Labs Names Experienced Pharma and Med Tech Executive David Pidduck, as CEO

PR Newswire April 20, 2022

The StockTalk Cannabis Report: April 8, 2022

Dave Jackson April 8, 2022

MediPharm Labs Continues to Lead with Innovation - Launches CBG and Water-Soluble Products

PR Newswire April 5, 2022

MediPharm Labs Reports Fourth Quarter and Full Year 2021 Results

PR Newswire March 31, 2022

MediPharm Labs Sets Date to Report Fourth Quarter and Full Year 2021 Financial Results

PR Newswire March 29, 2022

MediPharm Labs Strengthens Recreational Business Adding Flower and Pre-Rolls to Portfolio - Acquires IP from Canadian Consumer Favourite, Shelter Cannabis Brands

PR Newswire March 22, 2022